Bryan, D.Hart, P.Forsyth, K.Gibson, R.2006-12-032006-12-032005Lipids, 2005; 40(10):1007-10110024-42011558-9307http://hdl.handle.net/2440/17415Infection with respiratory syncytial virus (RSV) results in substantial infant morbidity and has been associated with the subsequent development of childhood asthma. Inflammatory mediators produced by both the epithelium and tissue leukocytes during RSV infection stimulate the release of chemotactic factors by the respiratory epithelium and the subsequent influx of inflammatory cells, predominantly neutrophils. We investigated the production of inflammatory mediators [prostaglandin E ₂ (PGE ₂), interleukin (IL)-1β, tumor necrosis factor α] and chemokines [IL-8, RANTES (regulation on activation, normal T cell expressed and secreted)] by alveolar epithelial cells in response to RSV infection. Infection of a human alveolar epithelial transformed cell line (A549 cells) with live RSV substantially increased production of PGE ₂, IL-8, and RANTES. By altering cell membrane FA through incorporation of the long-chain PUFA (LCPUFA) arachidonic acid, EPA, and DHA, we were subsequently able to significantly modulate PGE ₂ production by the infected epithelium. Because of the dynamic nature of the effects of PGE ₂ on lung function, regulation of this prostaglandin during RSV infection by n-3 LCPUFA has the potential to significantly alter the disease process.enRespiratory MucosaCell Line, TumorCell MembraneHumansRespiratory Syncytial Virus, HumanFatty Acids, Omega-3Docosahexaenoic AcidsEicosapentaenoic AcidArachidonic AcidDinoprostonePhospholipidsInterleukin-8Chemokine CCL5Journal article002005215910.1007/s11745-005-1463-40002334865000042-s2.0-3364487536753831Forsyth, K. [0000-0002-2748-0353]Gibson, R. [0000-0002-8750-525X]